IGMS NASDAQ
IGM Biosciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +10.4%
1Y: -85.7%
3Y: -95.1%
5Y: -97.7%
$1.27
Last traded 2025-08-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$3M
+25.8% ▲
Gross Profit
-$6M
-4.7% ▼
Operating Income
-$209M
+20.8% ▲
Net Income
-$196M
+20.5% ▲
EPS (Diluted)
$-3.24
+31.2% ▲
EBITDA
-$199M
+21.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $2M | $3M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +99.3% | +25.8% |
| Cost of Revenue | $4M | $8M | $11M | $8M | $9M |
| Gross Profit | -$4M | -$8M | -$10M | -$6M | -$6M |
| Gross Margin | — | — | -891.8% | -288.6% | -240.1% |
| R&D Expenses | $65M | $127M | $179M | $216M | $161M |
| SG&A Expenses | $18M | $38M | $50M | $50M | $50M |
| Operating Expenses | $83M | $165M | $229M | $266M | $211M |
| Operating Income | -$83M | -$165M | -$228M | -$263M | -$209M |
| Operating Margin | — | — | -21324.2% | -12369.1% | -7785.7% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$81M | -$165M | -$221M | -$246M | -$196M |
| Tax Expense | $0 | $0 | $0 | $678K | $0 |
| Net Income | -$80M | -$161M | -$214M | -$246M | -$196M |
| Net Margin | — | — | -20041.9% | -11568.8% | -7308.5% |
| EPS (Diluted) | $-2.61 | $-4.80 | $-5.16 | $-4.71 | $-3.24 |
| EBITDA | -$78M | -$157M | -$222M | -$255M | -$199M |
| Shares Outstanding | 31M | 33M | 42M | 52M | 61M |